Pharmacokinetic Properties of -Hydroxybutyrate (GHB) in Whole Blood, Serum, and Urine
Open Access
- 15 February 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Analytical Toxicology
- Vol. 36 (2) , 88-95
Abstract
Over the last 10–15 years, γ-hydroxybutyrate (GHB) and γ-butyrolactone have become increasingly popular “club drugs”, but they have also gained attention as potential agents of drug-facilitated sexual assault (DFSA). Several studies have attempted to characterize GHB's pharmacokinetic properties in humans, and the aim of this paper is to build on this research with an emphasis on DFSA cases. A 25 mg/kg dose of GHB was given to 12 GHB-naïve volunteers (6 men and 6 women). Urine and blood samples (serum and whole blood) were collected and analyzed by gas chromatography–mass spectrometry following liquid–liquid extraction. The urinary Tmax was 1 h in 11 volunteers with a mean Cmax of 67.6 mg/L (32.6–161.3 mg/L). Urinary concentrations rapidly decreased to < 10 mg/L (interpretive limit) for 11 volunteers after just 4 h. Data derived from whole blood (mean Cmax = 48.0 mg/L, Tmax = 24.6 min) closely matched that from serum (mean Cmax = 59.4 mg/L, Tmax = 23.3 min), suggesting GHB is distributed into erythrocytes. All 12 volunteers had GHB concentrations of less than 5 mg/L in both whole blood and serum after 3 h. Results verify the rapid elimination of GHB and the limited retrospective power of a concentration-based approach to prove GHB administration in blood and urine and confirm that, in DFSA cases, samples should be collected as soon as possible.Keywords
This publication has 44 references indexed in Scilit:
- Novel γ-Hydroxybutyric Acid (GHB) Analogs Share Some, but Not All, of the Behavioral Effects of GHB and GABAB Receptor AgonistsThe Journal of Pharmacology and Experimental Therapeutics, 2005
- Increased Production of Evoked and Spontaneous K-complexes Following a Night of Fragmented SleepSLEEP, 2002
- AN OPEN MULTICENTRIC STUDY EVALUATING 4-HYDROXYBUTYRIC ACID SODIUM SALT IN THE MEDIUM-TERM TREATMENT OF 179 ALCOHOL DEPENDENT SUBJECTSAlcohol and Alcoholism, 1996
- Clinical efficacy of gamma-hydroxybutyric acid in treatment of opiate withdrawalEuropean Archives of Psychiatry and Clinical Neuroscience, 1994
- Gamma-Hydroxybutyric Acid for Treatment of Opiate Withdrawal SyndromeNeuropsychopharmacology, 1993
- GAMMA-HYDROXYBUTYRIC ACID FOR TREATMENT OF ALCOHOL WITHDRAWAL SYNDROMEThe Lancet, 1989
- Treatment of Narcolepsy with γ-Hydroxybutyrate. A Review of Clinical and Sleep Laboratory FindingsSLEEP, 1986
- Conversion of γ‐Hydroxybutyrate to γ‐Aminobutyrate In VitroJournal of Neurochemistry, 1985
- Studies on the relation of γ-hydroxybutyric acid (GHB) to γ-aminobutyric acid (GABA): Evidence that GABA is not the sole source for GHB in rat brainBiochemical Pharmacology, 1982
- Gamma Hydroxybutyric AcidProceedings of the Royal Society of Medicine, 1968